French biotech Abivax has been the subject of intense takeover speculation for months. But a spokesperson denied a report by ...
AstraZeneca (LSE:AZN) has entered exclusive negotiations to potentially acquire biotech firm Abivax. The agreement gives ...
Fintel reports that on March 16, 2026, Jefferies initiated coverage of ABIVAX Société Anonyme - Depositary Receipt ...
British drugmaker AstraZeneca Plc AZN has emerged as the leading contender to acquire French biotech Abivax SA ABVX, ...
French biotech denies reports that AstraZeneca has exclusive access to its data as speculation swirls around a potential ...
The AMG TimesSquare Small Cap Growth Fund outperformed its benchmark in Q4 2025 behind strong tech and industrial gains. Read ...
Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX (Euronext Paris: FR0012333284 – ABVX) (Paris:ABVX), an innovative biotechnology company targeting the immune system to eliminate viral disease, ...
Abivax S.A. FR:ABVX has increased the size of its global offering to 20.33 million shares from 18.68 million shares as part of its uplisting to the Nasdaq under the ticker symbol “ABVX” from Euronext ...
By Sabrina Valle NEW YORK, March 12 (Reuters) - Biotechnology company Abivax on Thursday dismissed a report by French media ...